Conclusions: the enhanced level of serum soluble CD40L might be a reliable prognostic indicator for ACS and might be as a marker of the activity of the coronary lesion.
结论：血清可溶性CD 40 L升高是判断acs的可靠血清学指标，且可能是冠脉病变的活动性标志物。
CD40L may participate in thrombosis and activation of platelet. The soluble CD40L levels increase persistently in patients with acute cerebral infarction and acute coronary syndrome.
CD 40 L可能参与血栓形成和血小板活化，急性脑梗死和急性冠状动脉综合征患者血液中的可溶性CD 40 L持续性增高。
In KD patients, CD40L expression on CD4 + T-cells and E-selection was correlated with the occurrence of coronary artery lesions but not CD40L expression on CD8 + T-cells and not soluble CD40L levels.
细胞表面CD 40l表达及e -选择素与川崎病冠状动脉损伤有关，而CD 8 +T细胞表面CD 40l的表达及可溶性CD 40l与冠状动脉损伤无明显相关性。
Conclusion the soluble human CD40L truncate expressed in prokaryotic cells showed inhibiting effect on the growth of tumor cells.
结论原核表达的截断型人可溶性CD 4 0 L具有抑制肿瘤细胞生长作用。
Conclusion the soluble human CD40L truncate expressed in prokaryotic cells showed inhibiting effect on the growth of tumor cells.
结论原核表达的截断型人可溶性CD 4 0 L具有抑制肿瘤细胞生长作用。
应用推荐